Praxis precision medicines to present at 22nd annual needham virtual healthcare conference

Boston, april 06, 2023 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will present at the 22nd annual needham virtual healthcare conference on monday, april 17, 2023 at 12:45 p.m. et.
PRAX Ratings Summary
PRAX Quant Ranking